These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33987450)

  • 21. Patients' Perspectives on Attributes While Choosing Minimally Invasive Surgery for Benign Prostatic Hyperplasia Procedures: Experience from Men Undergoing Water Vapor Thermal Therapy.
    Rojanasarot S; Cutone B; Durand K; Zorn KC; Chughtai B; Bhojani N; Elterman DS
    J Endourol; 2023 May; 37(5):575-580. PubMed ID: 36762936
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.
    Elterman D; Shepherd S; Saadat SH; Alshak MN; Bhojani N; Zorn KC; Rijo E; Misrai V; Lajkosz K; Chughtai B
    Can J Urol; 2021 Oct; 28(5):10824-10833. PubMed ID: 34657655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of convective water vapor energy therapy versus prostatic urethral lift for symptomatic benign prostatic hyperplasia: a systematic review and indirect comparison.
    Tallman CT; Zantek PF; Hernandez N; Morton RA; Qi D; Gonzalez RR
    World J Urol; 2021 Sep; 39(9):3207-3215. PubMed ID: 33515055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rezūm water vapor thermal therapy in patients with benign prostatic hyperplasia: Initial real-world data from Japan.
    Obinata D; Mochida J; Uehara R; Osawa M; Hashimoto S; Nakahara K; Yoshizawa T; Yamaguchi K; Takahashi S
    Medicine (Baltimore); 2023 Nov; 102(46):e36055. PubMed ID: 37986385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: Systematic review and meta-analysis.
    Miller LE; Chughtai B; McVary K; Gonzalez RR; Rojanasarot S; DeRouen K; Bhattacharyya S
    Medicine (Baltimore); 2020 Jul; 99(30):e21365. PubMed ID: 32791742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cost-effectiveness analysis of pharmacotherapy versus prostatic urethral lift as initial therapy for patients with moderate benign prostatic hyperplasia.
    Tung JY; Aslim EJ; Ho HS; Chen C
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jan; 23(1):63-68. PubMed ID: 36342223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benign prostatic hyperplasia surgical re-treatment after prostatic urethral lift A narrative review.
    Dean NS; Assmus MA; Lee MS; Guo JN; Krambeck AE
    Can Urol Assoc J; 2023 Oct; 17(10):353-359. PubMed ID: 37494319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings.
    Eure G; Rukstalis D; Roehrborn C
    J Endourol; 2023 Jan; 37(1):50-59. PubMed ID: 35876440
    [No Abstract]   [Full Text] [Related]  

  • 29. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.
    Roehrborn CG; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Herron S; Rashid P; Rukstalis DB
    Can J Urol; 2017 Jun; 24(3):8802-8813. PubMed ID: 28646935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Ulchaker JC; Martinson MS
    Clinicoecon Outcomes Res; 2018; 10():29-43. PubMed ID: 29343977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study.
    Kaplan S; Kaufman RP; Mueller T; Elterman D; Chughtai B; Rukstalis D; Woo H; Roehrborn C
    Prostate Cancer Prostatic Dis; 2023 Oct; ():. PubMed ID: 37884615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of Water Vapor Thermal Therapy in the treatment of benign prostate hyperplasia: a systematic review and single-arm Meta-analysis.
    Yang J; Wu W; Amier Y; Li X; Wan W; Liu C; Zhang Y; Yu X
    BMC Urol; 2023 Apr; 23(1):72. PubMed ID: 37118692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injection.
    Tutrone RF; Schiff W
    Can J Urol; 2020 Jun; 27(3):10213-10219. PubMed ID: 32544043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Darson MF; Alexander EE; Schiffman ZJ; Lewitton M; Light RA; Sutton MA; Delgado-Rodriguez C; Gonzalez RR
    Res Rep Urol; 2017; 9():159-168. PubMed ID: 28861405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term cost effectiveness of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Pharmacoeconomics; 2006; 24(2):171-91. PubMed ID: 16460137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three year results of the prostatic urethral L.I.F.T. study.
    Roehrborn CG; Rukstalis DB; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rashid P
    Can J Urol; 2015 Jun; 22(3):7772-82. PubMed ID: 26068624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Systematic Review of Reported Ejaculatory Dysfunction in Clinical Trials Evaluating Minimally Invasive Treatment Modalities for BPH.
    Lokeshwar SD; Valancy D; Lima TFN; Blachman-Braun R; Ramasamy R
    Curr Urol Rep; 2020 Oct; 21(12):54. PubMed ID: 33104947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia.
    Dahm P; MacDonald R; McKenzie L; Jung JH; Greer N; Wilt T
    Eur Urol Open Sci; 2021 Apr; 26():72-82. PubMed ID: 34337510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.